Ghent University Academic Bibliography

Your filters: cql: author="Devos, Timothy" or (type any "bookEditor issueEditor" and editor="Devos, Timothy")

Add to list
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Timothy Devos, Quentin Van Thillo, Veerle Compernolle (UGent) , Tomé Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, et al.

(2022) EUROPEAN RESPIRATORY JOURNAL. 59(2).
Add to list
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, Daan Dierickx, Veerle Compernolle (UGent) , Geert Meyfroidt, Lore Vanderbeke, et al.

(2021) BRITISH JOURNAL OF HAEMATOLOGY. 192(6). p.1100-1105
Add to list
- Journal Article
- A1
- open access
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry

Timothy Devos, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Alain Gadisseur, Gaetan Vanstraelen, Helene Vellemans, Benjamin Bailly, Nikki Granacher, et al.

(2021) ANNALS OF HEMATOLOGY. 100(7). p.1723-1732
Add to list
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Timothy Devos, Tatjana Geukens, Alexander Schauwvlieghe (UGent) , Kevin K. Arien, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniel Desmecht, David Grimaldi, et al.

(2020) TRIALS. 21(1).
Add to list
Interruption or discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukaemia : a retrospective cohort study (SPARKLE) in Belgium

Timothy Devos, Gregor Verhoef, EVA STEEL (UGent) , Dominiek Mazure (UGent) , Philippe Lewalle, Dominique Bron, Zwi Berneman, Fleur Samantha Benghiat, Philippe Mineur, Koen Theunissen, et al.

(2019) ACTA HAEMATOLOGICA. 142(4). p.197-207

Academic Bibliography

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Interruption or discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukaemia : a retrospective cohort study (SPARKLE) in Belgium

Contents

Support

Contact